Fufeng Group Past Earnings Performance
Past criteria checks 2/6
Fufeng Group has been growing earnings at an average annual rate of 26%, while the Chemicals industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 14.9% per year. Fufeng Group's return on equity is 15.1%, and it has net margins of 9.5%.
Key information
26.0%
Earnings growth rate
26.1%
EPS growth rate
| Chemicals Industry Growth | 10.2% |
| Revenue growth rate | 14.9% |
| Return on equity | 15.1% |
| Net Margin | 9.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Fufeng Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 27,795 | 2,647 | 2,941 | 0 |
| 31 Mar 24 | 27,901 | 2,896 | 2,975 | 0 |
| 31 Dec 23 | 28,007 | 3,144 | 3,008 | 0 |
| 30 Sep 23 | 28,065 | 3,259 | 2,968 | 0 |
| 30 Jun 23 | 28,124 | 3,373 | 2,927 | 0 |
| 31 Mar 23 | 27,799 | 3,617 | 2,863 | 0 |
| 31 Dec 22 | 27,475 | 3,861 | 2,799 | 0 |
| 30 Sep 22 | 26,212 | 3,288 | 2,738 | 0 |
| 30 Jun 22 | 24,950 | 2,716 | 2,677 | 0 |
| 31 Mar 22 | 23,245 | 1,998 | 2,522 | 0 |
| 31 Dec 21 | 21,540 | 1,281 | 2,367 | 0 |
| 30 Sep 21 | 19,791 | 1,061 | 2,277 | 0 |
| 30 Jun 21 | 18,043 | 842 | 2,188 | 0 |
| 31 Mar 21 | 17,367 | 736 | 2,200 | 0 |
| 31 Dec 20 | 16,691 | 630 | 2,213 | 0 |
| 30 Sep 20 | 16,663 | 767 | 2,215 | 0 |
| 30 Jun 20 | 16,636 | 904 | 2,218 | 0 |
| 31 Mar 20 | 16,403 | 1,021 | 2,185 | 0 |
| 31 Dec 19 | 16,171 | 1,137 | 2,152 | 0 |
| 30 Sep 19 | 15,514 | 1,640 | 2,030 | 0 |
| 30 Jun 19 | 14,858 | 2,143 | 1,907 | 0 |
| 31 Mar 19 | 14,311 | 1,994 | 1,804 | 0 |
| 31 Dec 18 | 13,765 | 1,845 | 1,700 | 0 |
| 30 Sep 18 | 13,599 | 1,450 | 1,630 | 0 |
| 30 Jun 18 | 13,433 | 1,055 | 1,559 | 0 |
| 31 Mar 18 | 13,233 | 1,219 | 1,524 | 0 |
| 31 Dec 17 | 13,034 | 1,382 | 1,488 | 0 |
| 30 Sep 17 | 12,767 | 1,384 | 1,451 | 0 |
| 30 Jun 17 | 12,501 | 1,385 | 1,414 | 0 |
| 31 Mar 17 | 12,152 | 1,239 | 1,370 | 0 |
| 31 Dec 16 | 11,803 | 1,093 | 1,326 | 0 |
| 30 Sep 16 | 11,455 | 773 | 1,298 | 0 |
| 30 Jun 16 | 11,107 | 453 | 1,269 | 0 |
| 31 Mar 16 | 11,166 | 485 | 1,246 | 0 |
| 31 Dec 15 | 11,226 | 516 | 1,222 | 0 |
| 30 Sep 15 | 11,224 | 641 | 1,198 | 0 |
| 30 Jun 15 | 11,222 | 765 | 1,175 | 0 |
| 31 Mar 15 | 11,260 | 696 | 1,169 | 0 |
| 31 Dec 14 | 11,298 | 626 | 1,164 | 0 |
| 30 Sep 14 | 11,315 | 600 | 1,199 | 0 |
| 30 Jun 14 | 11,333 | 575 | 1,235 | 0 |
| 31 Mar 14 | 11,350 | 540 | 1,243 | 0 |
| 31 Dec 13 | 11,367 | 506 | 1,250 | 0 |
Quality Earnings: 546 has high quality earnings.
Growing Profit Margin: 546's current net profit margins (9.5%) are lower than last year (12%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 546's earnings have grown significantly by 26% per year over the past 5 years.
Accelerating Growth: 546's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 546 had negative earnings growth (-21.5%) over the past year, making it difficult to compare to the Chemicals industry average (-29.6%).
Return on Equity
High ROE: 546's Return on Equity (15.1%) is considered low.